FHIR IG analytics
| Package | hl7.fhir.uv.xver-r5.r4.r4 |
| Resource Type | ValueSet |
| Id | ValueSet-R5-medicinal-product-contact-type-for-R4.json |
| FHIR Version | R4 |
| Source | http://hl7.org/fhir/uv/xver-r5.r4/0.0.1-snapshot-2/ValueSet-R5-medicinal-product-contact-type-for-R4.html |
| URL | http://hl7.org/fhir/5.0/ValueSet/R5-medicinal-product-contact-type-for-R4 |
| Version | 0.0.1-snapshot-2 |
| Status | active |
| Date | 2025-09-01T22:37:02.779957+10:00 |
| Name | R5_medicinal_product_contact_type_for_R4 |
| Title | Cross-version VS for R5.ProductContactType for use in FHIR R4 |
| Realm | uv |
| Authority | hl7 |
| Description | This cross-version ValueSet represents concepts from http://hl7.org/fhir/ValueSet/medicinal-product-contact-type|5.0.0 for use in FHIR R4. Concepts not present here have direct `equivalent` mappings crossing all versions from R5 to R4. |
Resources that use this resource
Resources that this resource uses
Narrative
Note: links and images are rebased to the (stated) source
This value set expansion contains 5 concepts.
| Code | System | Display | Definition |
| ProposedMAH | http://hl7.org/fhir/medicinal-product-contact-type | Proposed Marketing Authorization Holder/Person | Proposed Marketing Authorization Holder/Person |
| ProcedureContactDuring | http://hl7.org/fhir/medicinal-product-contact-type | Person/Company authorised for Communication during procedure | Person/Company authorised for Communication on behalf of the Applicant during the Procedure |
| ProcedureContactAfter | http://hl7.org/fhir/medicinal-product-contact-type | Person/Company authorised for Communication after procedure | Person/Company authorised for Communication between MAH and Authorities after Authorization |
| QPPV | http://hl7.org/fhir/medicinal-product-contact-type | Qualified Person Responsible for Pharmacovigilance | Qualified Person Responsible for Pharmacovigilance |
| PVEnquiries | http://hl7.org/fhir/medicinal-product-contact-type | Pharmacovigilance Enquiry Information | Pharmacovigilance Enquiry Information |
Source1
{
"resourceType": "ValueSet",
"id": "R5-medicinal-product-contact-type-for-R4",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 1
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "brr"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r5.r4"
},
{
"url": "version",
"valueString": "0.0.1-snapshot-2"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/5.0/ImplementationGuide/hl7.fhir.uv.xver-r5.r4"
}
]
}
}
],
"url": "http://hl7.org/fhir/5.0/ValueSet/R5-medicinal-product-contact-type-for-R4",
"version": "0.0.1-snapshot-2",
"name": "R5_medicinal_product_contact_type_for_R4",
"title": "Cross-version VS for R5.ProductContactType for use in FHIR R4",
"status": "active",
"experimental": false,
"date": "2025-09-01T22:37:02.779957+10:00",
"publisher": "Biomedical Research and Regulation",
"contact": [
{
"name": "Biomedical Research and Regulation",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/rcrim"
}
]
}
],
"description": "This cross-version ValueSet represents concepts from http://hl7.org/fhir/ValueSet/medicinal-product-contact-type|5.0.0 for use in FHIR R4. Concepts not present here have direct `equivalent` mappings crossing all versions from R5 to R4.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/medicinal-product-contact-type",
"version": "5.0.0",
"concept": [
{
"code": "ProposedMAH",
"display": "Proposed Marketing Authorization Holder/Person"
},
{
"code": "ProcedureContactDuring",
"display": "Person/Company authorised for Communication during procedure"
},
{
"code": "ProcedureContactAfter",
"display": "Person/Company authorised for Communication after procedure"
},
{
"code": "QPPV",
"display": "Qualified Person Responsible for Pharmacovigilance"
},
{
"code": "PVEnquiries",
"display": "Pharmacovigilance Enquiry Information"
}
]
}
]
},
"expansion": {
"timestamp": "2025-09-01T22:37:02.779956+10:00",
"contains": [
{
"system": "http://hl7.org/fhir/medicinal-product-contact-type",
"version": "5.0.0",
"code": "ProposedMAH",
"display": "Proposed Marketing Authorization Holder/Person"
},
{
"system": "http://hl7.org/fhir/medicinal-product-contact-type",
"version": "5.0.0",
"code": "ProcedureContactDuring",
"display": "Person/Company authorised for Communication during procedure"
},
{
"system": "http://hl7.org/fhir/medicinal-product-contact-type",
"version": "5.0.0",
"code": "ProcedureContactAfter",
"display": "Person/Company authorised for Communication after procedure"
},
{
"system": "http://hl7.org/fhir/medicinal-product-contact-type",
"version": "5.0.0",
"code": "QPPV",
"display": "Qualified Person Responsible for Pharmacovigilance"
},
{
"system": "http://hl7.org/fhir/medicinal-product-contact-type",
"version": "5.0.0",
"code": "PVEnquiries",
"display": "Pharmacovigilance Enquiry Information"
}
]
}
}